Payment overview · 2025
General Payments
$13.53
1 reported records · 1 companies
Healthcare provider profile · identity verified
Ariel Ramirez Navarro, MD
Allopathic & Osteopathic Physicians|Internal Medicine · MIAMI, FL · NPI 1972755742
Verified facts
What the public records show
CMS Open Payments records show Ariel Ramirez Navarro, MD received $13.53 in general payments during 2025 across 1 reported records.
ACADIA Pharmaceuticals Inc accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ACADIA Pharmaceuticals Inc | Unresolved — no canonical attribution shown | $13.53 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $13.53 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| NUPLAZID Normalized: nuplazid |
Drug | ACADIA Pharmaceuticals Inc | $13.53 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1156 | 361 |
| Losartan Potassium | Losartan Potassium | 886 | 249 |
| Metformin Hcl | Metformin Hcl | 633 | 166 |
| Amlodipine Besylate | Amlodipine Besylate | 516 | 153 |
| Pantoprazole Sodium | Pantoprazole Sodium | 509 | 143 |
| Simvastatin | Simvastatin | 469 | 138 |
| Levothyroxine Sodium | Levothyroxine Sodium | 443 | 112 |
| Glipizide | Glipizide | 373 | 93 |
| Gabapentin | Gabapentin | 370 | 113 |
| Metoprolol Tartrate | Metoprolol Tartrate | 327 | 75 |
| Clopidogrel | Clopidogrel Bisulfate | 291 | 76 |
| Xarelto | Rivaroxaban | 291 | 40 |
| Tamsulosin Hcl | Tamsulosin Hcl | 281 | 91 |
| Lisinopril | Lisinopril | 268 | 87 |
| Temazepam | Temazepam | 267 | 46 |
| Hydrochlorothiazide | Hydrochlorothiazide | 266 | 77 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 266 | 54 |
| Unifine Pentips | Pen Needle, Diabetic | 256 | 40 |
| Metoprolol Succinate | Metoprolol Succinate | 249 | 88 |
| Alendronate Sodium | Alendronate Sodium | 232 | 53 |
| Tradjenta | Linagliptin | 221 | 28 |
| Sildenafil Citrate | Sildenafil Citrate | 209 | 52 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 205 | 70 |
| Escitalopram Oxalate | Escitalopram Oxalate | 202 | 56 |
| Alprazolam | Alprazolam | 201 | 38 |
| Omeprazole | Omeprazole | 193 | 62 |
| Chlorthalidone | Chlorthalidone | 190 | 61 |
| Carvedilol | Carvedilol | 187 | 52 |
| Nifedipine Er | Nifedipine | 180 | 44 |
| Eliquis | Apixaban | 164 | 37 |
| Furosemide | Furosemide | 164 | 37 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 159 | 49 |
| Latanoprost | Latanoprost | 143 | 25 |
| Pregabalin | Pregabalin | 137 | 28 |
| Famotidine | Famotidine | 136 | 45 |
| Pioglitazone Hcl | Pioglitazone Hcl | 131 | 24 |
| Hydralazine Hcl | Hydralazine Hcl | 128 | 28 |
| Potassium Chloride | Potassium Chloride | 123 | 30 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 122 | 48 |
| Metformin Hcl Er | Metformin Hcl | 111 | 26 |
| Donepezil Hcl | Donepezil Hcl | 110 | 32 |
| Baclofen | Baclofen | 108 | 86 |
| Montelukast Sodium | Montelukast Sodium | 108 | 33 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 106 | 42 |
| Glimepiride | Glimepiride | 104 | 26 |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 102 | 24 |
| Labetalol Hcl | Labetalol Hcl | 99 | 16 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 96 | 29 |
| Clonazepam | Clonazepam | 93 | 18 |
| Entresto | Sacubitril/Valsartan | 92 | 18 |
| Finasteride | Finasteride | 90 | 26 |
| Doxazosin Mesylate | Doxazosin Mesylate | 87 | 21 |
| Folic Acid | Folic Acid | 87 | 18 |
| Memantine Hcl | Memantine Hcl | 87 | 27 |
| Ketoconazole | Ketoconazole | 81 | 45 |
| Valsartan | Valsartan | 81 | 28 |
| Mirtazapine | Mirtazapine | 76 | 23 |
| Enalapril Maleate | Enalapril Maleate | 70 | 17 |
| Allopurinol | Allopurinol | 67 | 16 |
| Lorazepam | Lorazepam | 67 | 12 |
| Insulin Aspart Flexpen | Insulin Aspart | 66 | 15 |
| Zolpidem Tartrate | Zolpidem Tartrate | 66 | 13 |
| Meclizine Hcl | Meclizine Hcl | 59 | 33 |
| Quetiapine Fumarate | Quetiapine Fumarate | 59 | 23 |
| Tramadol Hcl | Tramadol Hcl | 59 | 36 |
| Clonidine | Clonidine | 58 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 57 | 35 |
| Irbesartan | Irbesartan | 56 | 18 |
| Meloxicam | Meloxicam | 56 | 46 |
| Duloxetine Hcl | Duloxetine Hcl | 55 | 12 |
| Synthroid | Levothyroxine Sodium | 55 | suppressed |
| Atenolol | Atenolol | 54 | 15 |
| Chlordiazepoxide Hcl | Chlordiazepoxide Hcl | 54 | 17 |
| Amiodarone Hcl | Amiodarone Hcl | 53 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 53 | 11 |
| Trulicity | Dulaglutide | 49 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 48 | 16 |
| Nystatin | Nystatin | 46 | 25 |
| Jardiance | Empagliflozin | 45 | suppressed |
| Sertraline Hcl | Sertraline Hcl | 45 | 14 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 44 | 16 |
| Brilinta | Ticagrelor | 43 | suppressed |
| Spironolactone | Spironolactone | 43 | 11 |
| Trazodone Hcl | Trazodone Hcl | 42 | 13 |
| Levetiracetam | Levetiracetam | 41 | suppressed |
| Trueplus Pen Needle | Pen Needle, Diabetic | 41 | 23 |
| Warfarin Sodium | Warfarin Sodium | 41 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 40 | 15 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 40 | suppressed |
| Ciclopirox | Ciclopirox | 40 | 21 |
| Ranolazine Er | Ranolazine | 40 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 39 | 18 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 37 | suppressed |
| Tadalafil | Tadalafil | 37 | 14 |
| Mupirocin | Mupirocin | 36 | 25 |
| Naproxen | Naproxen | 36 | 33 |
| Novolog Flexpen | Insulin Aspart | 36 | 11 |
| Ammonium Lactate | Ammonium Lactate | 35 | 24 |
| Fluticasone Propionate | Fluticasone Propionate | 35 | 21 |
| Ibandronate Sodium | Ibandronate Sodium | 35 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 35 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 33 | 30 |
| Azithromycin | Azithromycin | 32 | 24 |
| Benzonatate | Benzonatate | 32 | 28 |
| Midodrine Hcl | Midodrine Hcl | 32 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 31 | suppressed |
| Torsemide | Torsemide | 31 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 30 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 29 | 27 |
| Lansoprazole | Lansoprazole | 29 | 11 |
| Pravastatin Sodium | Pravastatin Sodium | 29 | suppressed |
| Prednisone | Prednisone | 29 | 13 |
| Benazepril Hcl | Benazepril Hcl | 28 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 28 | 21 |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 27 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 26 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 26 | 11 |
| Bumetanide | Bumetanide | 25 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 25 | 17 |
| Nexium | Esomeprazole Magnesium | 24 | suppressed |
| Ozempic | Semaglutide | 24 | suppressed |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 22 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 22 | suppressed |
| Ibuprofen | Ibuprofen | 22 | 18 |
| Methylprednisolone | Methylprednisolone | 22 | 15 |
| Fluoxetine Hcl | Fluoxetine Hcl | 21 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 21 | suppressed |
| Methotrexate | Methotrexate Sodium | 21 | suppressed |
| Procto-Med Hc | Hydrocortisone | 20 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 19 | 19 |
| Hydrocortisone | Hydrocortisone | 19 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 18 | suppressed |
| Glipizide-Metformin | Glipizide/Metformin Hcl | 18 | suppressed |
| Ramipril | Ramipril | 18 | suppressed |
| Trueplus Insulin Syringe | Syringe And Needle,insulin,1ml | 18 | suppressed |
| Cilostazol | Cilostazol | 17 | suppressed |
| Dabigatran Etexilate | Dabigatran Etexilate Mesylate | 17 | suppressed |
| Pentoxifylline | Pentoxifylline | 17 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 17 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 16 | suppressed |
| Ciclopirox | Ciclopirox Olamine | 16 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 16 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 16 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 15 | suppressed |
| Desonide | Desonide | 15 | suppressed |
| Fluconazole | Fluconazole | 15 | 11 |
| Glipizide Er | Glipizide | 15 | suppressed |
| Lovastatin | Lovastatin | 15 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 15 | suppressed |
| Bicalutamide | Bicalutamide | 14 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 14 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Nateglinide | Nateglinide | 14 | suppressed |
| Insulin Aspart Prot Mix 70-30 | Insulin Aspart Prot/Insuln Asp | 13 | suppressed |
| Lubiprostone | Lubiprostone | 13 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 13 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 13 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 12 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 12 | 11 |
| Clonidine Hcl | Clonidine Hcl | 12 | 11 |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 12 | suppressed |
| Diovan | Valsartan | 12 | suppressed |
| Fenofibrate | Fenofibrate | 12 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 12 | suppressed |
| Methimazole | Methimazole | 12 | suppressed |
| Methocarbamol | Methocarbamol | 12 | suppressed |
| Nitroglycerin | Nitroglycerin | 12 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 12 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 11 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 11 | suppressed |
| Lamotrigine | Lamotrigine | 11 | suppressed |
| Levofloxacin | Levofloxacin | 11 | suppressed |
| Metronidazole | Metronidazole | 11 | 11 |
| Tizanidine Hcl | Tizanidine Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $13.53 · 1 records | ACADIA Pharmaceuticals Inc | NUPLAZID | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error